NCT03147989View on ClinicalTrials.gov

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

CompletedOBSERVATIONAL
Enrollment

352

Participants

Timeline

Start Date

May 18, 2017

Primary Completion Date

December 7, 2017

Study Completion Date

March 16, 2018

Conditions
Central Nervous System DiseasesCentral Nervous System Neoplasms
Interventions
DRUG

MultiHance

gadolinium contrast agent

Trial Locations (1)

34239

Sarasota Memorial Hospital, Sarasota

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY